Redirecting Poor Sleep Drivers of Early Cardiovascular Disease
National University of Singapore
1,500 participants
Mar 24, 2025
OBSERVATIONAL
Conditions
Summary
Sleep health is a critical component of cardiovascular well-being, and poor sleep has been linked with increased risk for all-cause mortality including cardiovascular disease (CVD). Moreover, many individuals within a population may have underlying, subclinical cardiovascular conditions, such as hypertension and arterial stiffness, and these may risk progressing to advanced CVD when coupled with inadequate sleep duration and quality. Given that Singapore ranks as the third most sleep-deprived city globally, understanding the relationship between sleep health and the prevalence and progression of CVD becomes increasingly important for population health. In addition, depression and psychological stress could also lead to poorer cardiovascular health by increasing blood cholesterol, blood sugar and blood pressure, and could also be directly related to or arise as a result of poor sleep. The aim of the current study is to track sleep and mental health using a combination of objective sleep tracking (Oura ring) and smartphone-based questionnaires (EMA), and examine their associations with detailed cardiovascular health data collected by the project RESET (Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease).
Eligibility
Inclusion Criteria7
- Willing to wear a ring
- Have any of the following conditions:
- High blood pressure
- High cholesterol
- Fatty liver
- Family history of heart diseases or stroke.
- Obesity
Exclusion Criteria3
- Prior history of heart attack or stroke or balloon angioplasty/stent placement
- Restricted peripheral circulation (e.g., Raynaud's disease)
- Pacemakers
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06949722